Skip to content

Beta-galactosidase-1-like protein 3 (GLB1L3)

Homo sapiens — UniProt Q8NCI6

Gene: GLB1L3Homo sapiensSwissProt reviewed

Data last refreshed: (UniProt release unknown)

Key facts

Beta-galactosidase-1-like protein 3 (GLB1L3) is a protein from Homo sapiens identified by UniProt accession Q8NCI6, 653 residues long. MolForge cross-references it against 0 known binders and 30 disease associations.

  • UniProt accession: Q8NCI6; gene symbol GLB1L3.
  • Organism: Homo sapiens.
  • Length: 653 amino acids.
  • Top disease associations (Open Targets): neurodegenerative disease, genetic disorder and blood protein measurement.
  • 3D structure: AlphaFold model available.

Target properties

Protein nameBeta-galactosidase-1-like protein 3
UniProt accessionQ8NCI6
GeneGLB1L3
OrganismHomo sapiens
Length653 residues
Molecular weight—
EC numbers—
Target class—
Subcellular location—
Keywords—

Druggability

Target tractability assessment (Open Targets + pocket analysis). No approved drug

Druggability tierMEDIUM
Druggability score—
Pocket score—
Max clinical phase—

Disease associations (30)

Diseases linked to this target (Open Targets).

  • neurodegenerative disease · score 0.30
  • genetic disorder · score 0.12
  • blood protein measurement · score 0.09
  • metabolite measurement · score 0.09
  • body fat percentage · score 0.09
  • schizophrenia · score 0.08
  • body mass index · score 0.08
  • fat body mass · score 0.08
  • body weight · score 0.07
  • lean body mass · score 0.07

3D Structure (1)

Experimental (PDB) and predicted (AlphaFold) structures for this protein.

StructureSourceMethodMean pLDDTResolution (Å)
AF-Q8NCI6-F1alphafoldPREDICTED91.73—

Experimental structures are not indexed in MolForge yet — search RCSB PDB for Q8NCI6.

Amino-acid sequence (653 residues)

MKSPPLLSPC LSWKRMAGIF FLPFISSGFA PRFKQEENFM LGRAHPSQPR FNWSHLTPLE LKNRSVGLGT ESTGRGKPHF TLEGHKFLIF GGSIHYFRVP REYWRDRLLK LKACGFNTVT TYVPWNLHEP ERGKFDFSGN LDLEAFVLMA AEIGLWVILR PGRYICSEMD LGGLPSWLLQ DPRLLLRTTN KSFIEAVEKY FDHLIPRVIP LQYRQAGPVI AVQVENEYGS FNKDKTYMPY LHKALLRRGI VELLLTSDGE KHVLSGHTKG VLAAINLQKL HQDTFNQLHK VQRDKPLLIM EYWVGWFDRW GDKHHVKDAK EVEHAVSEFI KYEISFNVYM FHGGTNFGFM NGATYFGKHS GIVTSYDYDA VLTEAGDYTE KYLKLQKLFQ SVSATPLPRV PKLPPKAVYP PVRPSLYLPL WDALSYLNEP VRSRQPVNME NLPINNGSGQ SYGLVLYEKS ICSGGRLRAH AHDVAQVFLD ETMIGILNEN NKDLHIPELR DCRYLRILVE NQGRVNFSWQ IQNEQKGITG SVSINNSSLE GFTIYSLEMK MSFFERLRSA TWKPVPDSHQ GPAFYCGTLK AGPSPKDTFL SLLNWNYGFV FINGRNLGRY WNIGPQKTLY LPGVWLHPED NEVILFEKMM SGSDIKSTDK PTL

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

Which diseases are associated with GLB1L3?

The strongest Open Targets associations for GLB1L3 are neurodegenerative disease, genetic disorder, blood protein measurement, metabolite measurement and body fat percentage.

How long is the GLB1L3 protein?

The Homo sapiens GLB1L3 protein (UniProt Q8NCI6) is 653 amino acids long.

Browse: Targets: G · all protein targets A–Z · drugs A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Explore Beta-galactosidase-1-like protein 3 with MolForge

Find binders, run structure-based screening, and map this target across diseases and approved drugs with our AI-powered platform.

Browse all targets

Quick facts

UniProtQ8NCI6
GeneGLB1L3
OrganismHomo sapiens
Length653
Binders0
Diseases30
View on UniProt